Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease

Kate Kosmac, Ahmed Ismaeel, Daniel B. Kim-Shapiro, Mary M. McDermott

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)49-51
Number of pages3
JournalCirculation Research
Volume132
Issue number1
DOIs
StatePublished - Jan 6 2023

Bibliographical note

Funding Information:
M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.

Funding Information:
M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.

Keywords

  • Editorials
  • cilostazol
  • disability
  • nitric oxide
  • peripheral artery disease
  • revascularization
  • therapeutics

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease'. Together they form a unique fingerprint.

Cite this